ASX Filings

Opthea's Corporate Presentation - Jan 2025

January 14, 2025

Opthea to Host Investor Days in New York and Australia

January 8, 2025

Opthea Announces Publication in Diabetic Macular Edema

January 7, 2025

Application for quotation of securities - OPT

December 24, 2024

Notification regarding unquoted securities - OPT

December 24, 2024

Notification of cessation of securities - OPT

December 24, 2024

Notification regarding unquoted securities - OPT

December 24, 2024

Opthea to Present at 43rd J.P. Morgan Healthcare Conference

December 19, 2024

Change of Director's Interest Notice - SS

December 17, 2024

Change of Director's Interest Notice - SO

December 17, 2024